Sonoma Pharma Jumps 37% After Launch Of OTC Products On Amazon

Shares of nano-cap company Sonoma Pharmaceuticals, Inc. (SNOA) are surging over 37% on Tuesday morning after the company announced the launch of its first over-the-counter products in the U.S. on Amazon and a new consumer-focused product on Amazon in Europe.

SNOA is currently trading $7.38, down $2.03 or 37.94%, on the Nasdaq, on a volume of 28 million shares, far above average volume of 2.2 million shares. The stock has traded between $5.15 to $15.19 in the 52-week period.

Sonoma announced the over-the-counter consumer launch of Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser on Amazon.com as well as MucoClyns on Amazon sites in Europe. All three products are based on Sonoma's patented Microcyn technology and are immediately available for customer orders.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT